| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 758 | 2012 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 646 | 2013 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 548 | 2015 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 395 | 2017 |
| Cancer Progression and Tumor Cell Motility Are Associated with the FGFR4 Arg388 Allele J Bange, D Prechtl, Y Cheburkin, K Specht, N Harbeck, M Schmitt, ... Cancer research 62 (3), 840-847, 2002 | 382 | 2002 |
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 356 | 2017 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 329 | 2013 |
| Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives EN Imyanitov, AG Iyevleva, EV Levchenko Critical reviews in oncology/hematology 157, 103194, 2021 | 318 | 2021 |
| Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers KB Kuchenbaecker, L McGuffog, D Barrowdale, A Lee, P Soucy, J Dennis, ... JNCI: Journal of the National Cancer Institute 109 (7), djw302, 2017 | 318 | 2017 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 307 | 2015 |
| Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses H Zhang, TU Ahearn, J Lecarpentier, D Barnes, J Beesley, G Qi, X Jiang, ... Nature genetics 52 (6), 572-581, 2020 | 305 | 2020 |
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 291 | 2018 |
| Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction AC Antoniou, J Beesley, L McGuffog, OM Sinilnikova, S Healey, ... Cancer research 70 (23), 9742-9754, 2010 | 257 | 2010 |
| EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer E Tulchinsky, O Demidov, M Kriajevska, NA Barlev, E Imyanitov Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1871 (1), 29-39, 2019 | 172 | 2019 |
| Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review S Raimondi, V Paracchini, H Autrup, JM Barros-Dios, S Benhamou, ... American journal of epidemiology 164 (11), 1027-1042, 2006 | 170 | 2006 |
| Bardet-biedl syndrome EN Suspitsin, EN Imyanitov Molecular syndromology 7 (2), 62-71, 2016 | 153 | 2016 |
| Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 AM Dunning, K Michailidou, KB Kuchenbaecker, D Thompson, JD French, ... Nature genetics 48 (4), 374-386, 2016 | 153 | 2016 |
| Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... Nature genetics 52 (1), 56-73, 2020 | 149 | 2020 |
| On the origin and diffusion of BRCA1 c. 5266dupC (5382insC) in European populations N Hamel, BJ Feng, L Foretova, D Stoppa-Lyonnet, SA Narod, E Imyanitov, ... European Journal of Human Genetics 19 (3), 300-306, 2011 | 149 | 2011 |
| Mechanisms of acquired tumor drug resistance SN Aleksakhina, A Kashyap, EN Imyanitov Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1872 (2), 188310, 2019 | 147 | 2019 |
